Directory
>
Arthur Kuan
Arthur Kuan
Analyst | The Lustgarten Foundation
California, Irvine, United States
Arthur Kuan
Summary
Arthur Kuan is a dynamic leader in the field of oncology, currently serving as the Chairman and CEO of CG Oncology, a company dedicated to developing innovative therapies for urologic cancer. His career trajectory showcases a strong commitment to healthcare advancement, highlighted by his recognition as a 2020 Forbes 30 Under 30 honoree in Healthcare. With a solid educational foundation in molecular biology and biotechnology from prestigious institutions like the University of Pennsylvania and Johns Hopkins University, Arthur combines scientific expertise with strategic leadership. His previous roles include COO at CG Oncology and advisory positions at Moffitt Cancer Center, where he contributed to intellectual property commercialization. Arthur's vision for CG Oncology is to enhance the quality of life for cancer patients through groundbreaking treatments. He is passionate about the intersection of science and business, driving commercialization strategies that bring innovative solutions to market.
Arthur Kuan
Work Experience
Board Member at
The Lustgarten Foundation
June 2025 - Present
Arthur Kuan
Education
Stevenson School
University of Pennsylvania, Bachelor of Arts (B.A.), Molecular Biology
Johns Hopkins University, Master of Science (M.S.), Biotechnology
Frequently Asked Questions about Arthur Kuan
What is Arthur Kuan email address?
Arthur Kuan's primary email address is ***********@coldgenesys.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Arthur Kuan work for?
Arthur Kuan is a Analyst at The Lustgarten Foundation.
Where Arthur Kuan graduated from?
Arthur Kuan holds a degree in null from Stevenson School.
How can I directly contact Arthur Kuan?
To contact Arthur Kuan directly, you can use the email address ***********@coldgenesys.com. Complete contact information is available upon registration with Muraena.
Who is Arthur Kuan?
Arthur Kuan is a dynamic leader in the field of oncology, currently serving as the Chairman and CEO of CG Oncology, a company dedicated to developing innovative therapies for urologic cancer. His career trajectory showcases a strong commitment to healthcare advancement, highlighted by his recognition as a 2020 Forbes 30 Under 30 honoree in Healthcare. With a solid educational foundation in molecular biology and biotechnology from prestigious institutions like the University of Pennsylvania and Johns Hopkins University, Arthur combines scientific expertise with strategic leadership. His previous roles include COO at CG Oncology and advisory positions at Moffitt Cancer Center, where he contributed to intellectual property commercialization. Arthur's vision for CG Oncology is to enhance the quality of life for cancer patients through groundbreaking treatments. He is passionate about the intersection of science and business, driving commercialization strategies that bring innovative solutions to market.
Arthur`s contact details
***********@coldgenesys.com
***********@aicgroup.com.tw
*****@moffitt.org
***********@ally-bridge.com
***********@cgoncology.com
Colleagues
Director